by RSM US LLP | Mar 17, 2023
Insights < Back to Insights and Resources Leveraging technology to enhance profitability and contract performanceARTICLE | March 17, 2023Authored by RSM US LLPOperating in the life sciences industry can bring a variety of challenges around the visibility and...
by RSM US LLP | Mar 13, 2023
Insights < Back to Insights and Resources Contract management: What it means and how to optimize key processesARTICLE | March 13, 2023Authored by RSM US LLPContract management is a critical element of success for pharmaceutical companies. Organizations must...
by RSM US LLP | Sep 22, 2022
Insights < Back to Insights and Resources Where economics and life sciences collide: Industry trends to watchARTICLE | September 22, 2022Authored by RSM US LLPFollowing a summer lull in meetings with boards and leadership groups, we are once again sitting down...
by RSM US LLP | Jul 12, 2022
Insights < Back to Insights and Resources Top trends affecting middle market medtech companiesARTICLE | July 12, 2022Authored by RSM US LLPExperts say that even after the immediate emergency of the current COVID-19 pandemic passes, the health care industry won't...
by RSM US LLP | Feb 10, 2022
Insights < Back to Insights and Resources Proposed PFIC regulations revise reporting by US partnerships TAX ALERT | February 10, 2022 Authored by RSM US LLPOn Jan. 24, 2022, the IRS issued proposed regulations (REG-118250-20) that would eliminate the Form 8621...
Recent Comments